Business
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
Launching into this growth market1 as part of the company’s geographic expansion strategy Evolus Australia established to drive medical education, training,
About this update from Evolus, Inc. Common Stock
[{"type":"text","content":"\n\nLaunching into this growth market1 as part of the company’s geographic expansion strategy\n\n\n\nEvolus Australia established to drive medical education, training, marketing and sales to medical aesthetics healthcare professionals\n\n\n\n NEWPORT BEACH, Calif.--(BUSINESS WIRE)--\nEvolus, Inc. (NASDAQ: EOLS), a performance beauty company focused on building an aesthetic portfolio, has commenced operations in Australia with the launch of Nuceiva® (prabotulinumtoxinA).\n\n\nNuceiva® is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients2.\n\n\n\"Launching Evolus in Australia underscores our commitment to strategic geographic expansion and our dedicated focus on customers in this growth market,\" said David Moatazedi, President and Chief Executive Officer. \"This milestone fuels our global growth strategy by establishing a strong presence in a key region. Successfully entering new markets like Australia positions us for sustained above-market growth, reinforcing Evolus' position as a global leader in its industry.\"\n\n\nEvolus has established a direct operating entity in Australia, under the leadership of Daniel Henry. Working closely with aesthetics healthcare professionals will enable Evolus to offer this new treatment to patients. Nuceiva® is licensed in the United States under the brand name Jeuveau® and has been the fastest-growing neurotoxin in the United States for three consecutive years*.\n\n\n\"As the beauty and healthcare landscape continues to evolve, we understand the importance of working closely with our customers and partners to navigate these changes successfully,\" said Dan Stewart, Vice President and General Manager of Evolus International. \"I have full confidence in Daniel Henry, who brings a wealth of experience and vision to our team. We are dedicated to supporting Australian healthcare professionals by providing exceptional customer service, innovative educational initiatives, and a user-friendly online service platform to help evolve their practices and continually deliver outstanding patient satisfaction.\"\n\n\n\"Beauty in Australia is evolving as younger generations get curious about non-surgical enhancement and rejuvenation options,” said Dr. Steven Liew, renowned Plastic Surgeon and Medical Di...